Paul Curmi

Paul Curmi is a Director of Product Management at Napier Park. Napier Park separated from Citigroup’s alternative investment arm, Citi Capital Advisors, in February 2013. In addition to his role in Product Management, Paul is the Chairman of the firm’s ESG Committee. Paul graduated from Fordham University with a B.S. in Business Administration. Paul is on the Board of Directors of Advancing CTNNB1 Cures and Treatments, a non-profit which supports the development of treatments and cures for CTNNB1 Syndrome.